Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06908512

Adaptation of the Intensive Care Unit-specific Pressure Injury Risk Scale to Turkish (RAPS-ICU)

The aim of this study was to evaluate the translation, cross-cultural fit, and psychometric properties of the ICU-specific pressure injury risk scale

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Harran University

Sanliurfa, Turkey, 63000, Turkey (Türkiye)

About this study

This was a prospective, cross-sectional study aimed at translation and cultural adaptation of the RAPS-ICU into Turkish, while also assessing its validity and reliability.Patients who meet the inclusion criteria and who are hospitalized in the Intensive Care Clinics of Istinye University Bahçeşehir Liv Hospital and Harran University Hospital will participate in the study. In this study, Turkish adaptation of the 'Intensive care unit-specific pressure injury risk assessment scale' is planned. After language adaptation, its validity and reliability will be tested. The reliability of the intensive care unit-specific pressure injury risk assessment scale will be assessed by inter-rater reliability and internal consistency (determined by calculating Cronbach alpha coefficient), and its validity will be assessed by convergent and divergent validity of the scale. Relative reliability was obtained by calculating the intraclass correlation coefficient (ICC). Relative reliability will be obtained by calculating the intraclass correlation coefficient (ICC). The receiver operator characteristics (ROC) curve has been used to estimate sensitivity and specificity and will represent the false positive rate versus the true positive rate across various thresholds for different scores.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older,
  • Staying in the Intensive Care Unit for at least 1 day,
  • Agreeing to participate in the study by themselves or a family member.
  • Volunteering to participate in the research
  • Full orientation and no psychiatric problems

Exclusion criteria

  • Having communication problems

Treatment and study plan

Primary outcomes

  1. ICU-Specific Pressure Injury Risk Assessment Scale (RAPS-ICU)

    Time frame: Baseline

    The RAPS-ICU was developed by W°ahlin et al to identify patients at risk of developing pressure injuries in the ICU. The RAPS-ICU has six domains that assess failure in vital organs, mobility, moisture, sensory perceptions, special treatments, and consciousness. Five of the six domains scored 1-4 points progressing from most to least severity of alteration; failure in vital organs domains ranged from 1-3 points. Overall PI risk is reflected by a total score ranging from 6 to 23. The lower the total score the greater the estimated risk of developing a PI. Risk scores can be categorized as increased (16-18), high (12-15), and very high (≤11) risk for PI.

Study contacts

Contact information is provided by the study sponsor or research team.

Ibrahim C Dikici, Assist. Prof.

CONTACT

[email protected]

+905376729057

Yunus E Tütüneken, Research Assistant

CONTACT

[email protected]

+905435912455

Sponsors and collaborators

Lead sponsor

Harran University

Other

Registry information

Official study title

Turkish Adaptation, Validity and Reliability of the Intensive Care Unit-specific Pressure Injury Risk Assessment Scale

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Apr 3, 2025
Registry last updated
Apr 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.